To return to some semblance of “normal” after COVID-19 lockdowns, companies are eyeing digital screening platforms to verify someone’s COVID-19 negativity or vaccine status before attending large gatherings. That software may soon come to fruition—and it may not face many barriers to adoption. In fact, lawyers noted that such efforts wouldn’t likely be hindered by data privacy or litigation hurdles so long as they require consent and limit their collection of personally identifiable information (PII).
In November 2020, Ticketmaster revealed its framework for post-pandemic public events, which would include COVID-19 vaccination confirmation or attendees being tested 24 to 72 hours before an event, per the venue’s or state’s requirements. The attendee would tell a lab to deliver their test results or deliver their vaccine status to Ticketmaster’s “health pass” providers. Ticketmaster noted it wouldn’t store or access an attendee’s medical records, but would only receive verification from its providers if the person is cleared to attend an event.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]